Abiopharma

New Form 424B3 - Jaguar Health, Inc. Filed: 2025-06-27 AccNo: 0001193125-25-151392 Size: 341 KB

New Form 8-K - INCYTE CORP Filed: 2025-06-27 AccNo: 0001104659-25-063675 Size: 769 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

New Form 6-K - Biodexa Pharmaceuticals Plc Filed: 2025-06-27 AccNo: 0001214659-25-009724 Size: 42 KB

New Form 11-K - Sanofi Filed: 2025-06-27 AccNo: 0001104659-25-063672 Size: 461 KB

New Form POS AM - bioAffinity Technologies, Inc. Filed: 2025-06-27 AccNo: 0001641172-25-016923 Size: 10 MB

New Form 11-K - Sanofi Filed: 2025-06-27 AccNo: 0001104659-25-063669 Size: 334 KB

New Form 8-K - Praxis Precision Medicines, Inc. Filed: 2025-06-27 AccNo: 0001689548-25-000075 Size: 159 KB Item 5.07: Submission of Matters to a Vote of Security Holders

New Form S-3/A - AIM ImmunoTech Inc. Filed: 2025-06-27 AccNo: 0001641172-25-016918 Size: 364 KB

New Form 8-K/A - HARVARD BIOSCIENCE INC Filed: 2025-06-27 AccNo: 0001171843-25-004196 Size: 209 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 9.01: Financial Statements and Exhibits

New Form 10-Q - EXICURE, INC. Filed: 2025-06-27 AccNo: 0001698530-25-000056 Size: 5 MB